Zobrazeno 1 - 10
of 113
pro vyhledávání: '"Edward N, Libby"'
Autor:
Solomon A. Graf, Ryan C. Lynch, Chaitra S. Ujjani, Ted A. Gooley, Heather Rasmussen, David G. Coffey, Andrew J. Cowan, Stephen D. Smith, Mazyar Shadman, Edus H. Warren, Edward N. Libby, Alexander L. Greninger, Jonathan R. Fromm, Ajay K. Gopal
Publikováno v:
Blood advances.
Patients with indolent B-cell non-Hodgkin lymphoma (iNHL) generally require treatment but experience normal survival, emphasizing the need for simpler, safer therapies. Proteasome inhibitors target aberrant signaling pathways within iNHL and have man
Autor:
Hani Hassoun, Susanna J Jacobus, Paul G. Richardson, Jeffrey Zonder, Peter M. Voorhees, Jonathan L. Kaufman, Andrew J Yee, Emma C Scott, Pallawi Torka, Edward N. Libby, Brandi Reeves, Michael L. Wang, Larry D. Anderson, Carter Milner, Cristina Gasparetto, Mounzer Agha, Dr. Abdullah Khan, David D Hurd, David E. Avigan, Caitlin Costello, Andrzej Jakubowiak, Sagar Lonial, Noopur S Raje, Eva Medvedova, Dr. Philip L. McCarthy, Robert Z. Orlowski, Omar Nadeem, Jacob Laubach, Marcelo Pasquini, Sergio Giralt, Kelly Masone, Mehmet Samur, Aurore Perrot, Philippe Moreau, Hervé Avet-Loiseau, Edie Weller, Nikhil C. Munshi, Kenneth C. Anderson
Publikováno v:
Transplantation and Cellular Therapy. 29:S396-S397
Autor:
Hilary Coye, Mazyar Shadman, Karolyn Morris, Christen N. Martino, Andrei R. Shustov, Edus H. Warren, Brian G. Till, Heather Rasmussen, Jenna M. Voutsinas, Sandra L Bhark, Jonathan R. Fromm, Chaitra S. Ujjani, Ryan D. Cassaday, Edward N. Libby, Mary Philip, Andrew J. Cowan, Stephen D. Smith, Sanaz Behnia, Ryan C. Lynch, Ajay K. Gopal
Publikováno v:
The Lancet Haematology. 8:e562-e571
Summary Background Relapsed or refractory classical Hodgkin lymphoma could be treated with multiagent salvage chemotherapy followed by autologous haematopoietic stem-cell transplantation. The aim of this study is to establish the safety and activity
Autor:
Franck, Morschhauser, Loretta, Nastoupil, Pierre, Feugier, Jean-Marc, Schiano de Colella, Hervé, Tilly, Maria Lia, Palomba, Emmanuel, Bachy, Christophe, Fruchart, Edward N, Libby, Rene-Olivier, Casasnovas, Ian W, Flinn, Corinne, Haioun, Hervé, Maisonneuve, Loic, Ysebaert, Nancy L, Bartlett, Kamal, Bouabdallah, Pauline, Brice, Vincent, Ribrag, Steven, Le Gouill, Nicolas, Daguindau, Stéphanie, Guidez, Gian Matteo, Pica, Alejandro Martín, García-Sancho, Armondo, López-Guillermo, Jean-François, Larouche, Kiyoshi, Ando, Maria, Gomes da Silva, Marc, André, Wu, Kalung, Laurie H, Sehn, Koji, Izutsu, Guillaume, Cartron, Argyrios, Gkasiamis, Russell, Crowe, Luc, Xerri, Nathan H, Fowler, Gilles, Salles
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 40(28)
Autor:
Paul G, Richardson, Susanna J, Jacobus, Edie A, Weller, Hani, Hassoun, Sagar, Lonial, Noopur S, Raje, Eva, Medvedova, Philip L, McCarthy, Edward N, Libby, Peter M, Voorhees, Robert Z, Orlowski, Larry D, Anderson, Jeffrey A, Zonder, Carter P, Milner, Cristina, Gasparetto, Mounzer E, Agha, Abdullah M, Khan, David D, Hurd, Krisstina, Gowin, Rammurti T, Kamble, Sundar, Jagannath, Nitya, Nathwani, Melissa, Alsina, R Frank, Cornell, Hamza, Hashmi, Erica L, Campagnaro, Astrid C, Andreescu, Teresa, Gentile, Michaela, Liedtke, Kelly N, Godby, Adam D, Cohen, Thomas H, Openshaw, Marcelo C, Pasquini, Sergio A, Giralt, Jonathan L, Kaufman, Andrew J, Yee, Emma, Scott, Pallawi, Torka, Amy, Foley, Mariateresa, Fulciniti, Kyle, Hebert, Mehmet K, Samur, Kelly, Masone, Michelle E, Maglio, Andrea A, Zeytoonjian, Omar, Nadeem, Robert L, Schlossman, Jacob P, Laubach, Claudia, Paba-Prada, Irene M, Ghobrial, Aurore, Perrot, Philippe, Moreau, Hervé, Avet-Loiseau, Michel, Attal, Kenneth C, Anderson, Nikhil C, Munshi, Hillard, Lazarus
Publikováno v:
N Engl J Med
BACKGROUND: In patients with newly diagnosed multiple myeloma, the effect of adding autologous stem-cell transplantation (ASCT) to triplet therapy (lenalidomide, bortezomib, and dexamethasone [RVD]), followed by lenalidomide maintenance therapy until
Autor:
Hartmut Goldschmidt, Christoph Heuck, Markus Munder, Edward N. Libby, Maria Teresa Petrucci, Mehmet Turgut, Michele Cavo, Tobias Neff, Ming Qi, Katja Weisel, Robert Kleiman, Mario Boccadoro, Fatih Demirkan, Steven Kuppens, Ihsan Karadogan, Ajai Chari, Pamela L. Clemens, Rajesh Bandekar, Ceri Bygrave, Matthew W Jenner, Niels W.C.J. van de Donk
Publikováno v:
Advances in Therapy
Introduction Daratumumab is a CD38-targeting monoclonal antibody that has demonstrated clinical benefit for multiple myeloma. Daratumumab inhibition of CD38, which is expressed on immune cell populations and cardiomyocytes, could potentially affect c
Autor:
Jin Lu, Kenshi Suzuki, Edward N. Libby, Dominique Chauveau, Xiang Qin, Giovanni Palladini, Hans C. Lee, Naresh Bumma, Katharine S. Gries, Moshe E. Gatt, Raymond L. Comenzo, Sandra Y. Vasey, Brendan M. Weiss, Jason Valent, Michael Rosenzweig, Arnaud Jaccard, Monique C. Minnema, Peter Mollee, Vaishali Sanchorawala, Meral Beksac, Jessica Vermeulen, Simon D. J. Gibbs, Kihyun Kim, Ashutosh Wechalekar, Christopher P. Venner, John Fastenau, Brenda Tromp, Stefan Schönland, Namphuong Tran, Vania Hungria, Sandy W. Wong, Giampaolo Merlini, M. Teresa Cibeira, Efstathios Kastritis
Publikováno v:
Blood. 136:37-40
Background: Systemic AL amyloidosis is a rare disease characterized by amyloid fibril deposits, most commonly in the heart and kidneys; there are currently no health authority-approved treatments. Therapies for the treatment of multiple myeloma (MM),
Autor:
Damian J. Green, Andrei R. Shustov, Chaitra S. Ujjani, Mary Elizabeth Percival, Andrew J. Cowan, Mazyar Shadman, Edward N. Libby, Stephen D. Smith, Ajay K. Gopal, Anna B. Halpern, Ryan C. Lynch, Bart L. Scott, Ryan D. Cassaday, Yolanda D. Tseng, Catherine Liu, Steven A. Pergam
Publikováno v:
JCO Oncol Pract
In January 2020, the first documented patient in the United States infected with severe acute respiratory syndrome coronavirus 2 was diagnosed in Washington State. Since that time, community spread of coronavirus disease 2019 (COVID-19) in the state
Publikováno v:
Annals of Hematology. 99:121-126
It is uncertain if different immunomodulatory drugs (IMID) pose distinct thrombotic risk in patients with newly diagnosed multiple myeloma (MM). Among 2397 MM patients from the SEER-Medicare database from 2007 to 2013, 78% received lenalidomide, and
Autor:
Sandy W. Wong, Edward N. Libby, Giampaolo Merlini, Giovanni Palladini, Brendan M. Weiss, Naresh Bumma, Kihyun Kim, Meletios A. Dimopoulos, Hans C. Lee, Vania Hungria, M. Teresa Cibeira, Raymond L. Comenzo, Efstathios Kastritis, Monique C. Minnema, Jessica Vermeulen, Namphuong Tran, Brenda Tromp, Jason Valent, Meral Beksac, Simon D. J. Gibbs, Xiang Qin, Arnaud Jaccard, Vaishali Sanchorawala, Peter Mollee, Jin Lu, Kenshi Suzuki, Dominique Chauveau, Christopher P. Venner, Ashutosh D. Wechalekar, Stefan Schönland, Michael Rosenzweig, Sandra Y. Vasey, Moshe E. Gatt
Publikováno v:
Blood. 136:48-50
Background: Systemic AL amyloidosis is characterized by the deposition of insoluble amyloid fibrils produced by light chains synthesized by clonal CD38+ plasma cells. Combining daratumumab (DARA) with bortezomib, cyclophosphamide, and dexamethasone (